Target will rise with every update I feel. Reflecting on recent corporate transactions in this space, we can confidently say that Clarity will achieve a significant premium to the current valuation which I believe would dwarf recent deals.
Clarity is on the verge of becoming the Gold Standard for cancer diagnosis and treatment, and will ultimately be across many types of cancers. We are at the beginning of something spectacular in the medical world, changing lives and building tremendous value for shareholders too.
I have been adding when funds permit.
Research/Valuation, page-226
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.13 |
Change
0.060(1.47%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $4.11 | $4.20 | $4.07 | $2.593M | 624.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 6074 | $4.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.13 | 2441 | 1 |
View Market Depth
| Last trade - 16.10pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.13 |
Change
0.060 ( 1.71 %) |
||||
| Open | High | Low | Volume | ||
| $4.11 | $4.21 | $4.10 | 48821 | ||
| Last updated 15.59pm 23/05/2024 ? | |||||
| CU6 (ASX) Chart |